FDA Drug recall D-0304-2020
Cephalexin for Oral Suspension USP, 250 mg/5mL, 200 mL bottle, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc. 111 South Calvert Str…
- FDA Drug
- Class III
- terminated
- Published 2019-11-13
On 2019-11-13 the FDA classified a Class III recall of Cephalexin for Oral Suspension USP, 250 mg/5mL, 200 mL bottle, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc. 111 South Calvert Str… by Lupin Pharmaceuticals, citing presence of Foreign substance: identified as a dead ant.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0304-2020 |
| Classification | Class III |
| Status | terminated |
| Initiated | 2019-11-01 |
| Published | 2019-11-13 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Lupin Pharmaceuticals |
| Distribution | US |
Product
Cephalexin for Oral Suspension USP, 250 mg/5mL, 200 mL bottle, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc. 111 South Calvert Street, Baltimore, Maryland 21202, United States, Manufactured by: Lupin Limited, Mumbai 400 098 INDIA, NDC 68180-0441-02
Reason
Presence of Foreign substance: identified as a dead ant.
Identifiers
| code_info | Lot #: F802436, F802437, F802438, F802442, Exp 11/20 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0304-2020%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.